Author

J. Sevilla

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

A. Sanchez· 1 shared B. Beamud· 1 shared B. Fuster-Escriva· 1 shared C. Gimeno· 1 shared E. Sebastian· 1 shared E. Vuelta· 1 shared F. Gonzalez-Candelas· 1 shared F. Sanchez-Guijo· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Sanchez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Tracking the emergence and dissemination of a blaNDM-23 Gene in a Multi-Drug Resistance Plasmid of Klebsiella pneumoniae

N. Garcia-Gonzalez, B. Beamud, B. Fuster-Escriva, S. Giner, M. V. Domniguez Marquez, A. Sanchez, J. Sevilla, T. Coque, C. Gimeno, F. Gonzalez-Candelas

This study characterizes the emergence and spread of a novel blaNDM-23 gene in a multidrug-resistant plasmid of Klebsiella pneumoniae across Spanish hospitals.

bioRxiv · Jul 5, 2022 · PreprintMicrobiology

CRISPR/Cas9 technology abolishes the BCR/ABL1 oncogene effect in chronic myeloid leukemia and restores normal hematopoiesis

E. Vuelta, J. L. Ordonez, V. Alonso-Perez, L. Mendez, P. Hernandez-Carabias, R. Saldana, J. Sevilla, E. Sebastian, S. Muntion, F. Sanchez-Guijo, J. M. Hernandez-Rivas, I. Garcia-Tunon, M. A. Sanchez-Martin

This study uses CRISPR/Cas9 to target and disrupt the BCR/ABL1 oncogene in CML cells, restoring normal hematopoiesis in mouse models and patient-derived xenografts.

bioRxiv · Aug 5, 2020 · PreprintCancer Biology